Article Correctness Is Author's Responsibility: sphingotec’s endothelial function biomarker bio-ADM® predicts need for organ support in general ICU patient population

(sphingotec GmbH) Data from more than 2,000 patients enrolled in the FROG-ICU study demonstrate that high levels of bioactive adrenomedullin (bio-ADM®) predict the need for organ support, ionotropes, and vasopressors in the general patient population at admission to the intensive care unit (ICU).